根据最近的报导,应用单一药物或联合化疗方法治疗肝细胞癌的疗效甚差。作者提出用5—氟尿嘧啶(5—Fu)、氨甲喋呤(MTX)和强的松龙合并化疗的新方案(FAP 方案)治疗肝细胞癌取得了较好的效果。本研究的11例患者均由组织学证实为肝细胞癌。治疗前均进行血细胞计数、血小板计数或血涂片检查、胸部 X 光照片、肝扫描及肝肾功的常规化验。治疗期间每周至少作一次血液检查。治疗方案的实施如下表所示: According to a recent report, the use of a single drug or combination chemotherapy for the treatment of hepatocellular carcinoma is poor. The authors suggest that a new regimen of 5-fluorouracil (5-Fu), methotrexate (MTX) and prednisolone combined with chemotherapy (FAP regimen) for hepatocellular carcinoma has achieved good results. Eleven patients in this study were confirmed by histology as hepatocellular carcinoma. Blood count, platelet count or blood smears, chest X-ray, liver scan and liver and kidney routine tests were performed before treatment. At least once a week during the treatment of blood tests. The treatment plan is shown in the following table: